These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1480920)

  • 21. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis.
    Reeves MF; Smith KJ; Creinin MD
    Obstet Gynecol; 2007 Jun; 109(6):1286-94. PubMed ID: 17540799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wider opportunities for IUD insertion.
    Cole LP; Potts DM
    IPPF Med Bull; 1983 Feb; 17(1):2-3. PubMed ID: 12264751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of long-term use of intrauterine devices.
    Hata Y; Ishihama A; Kudo N; Nakamura Y; Miyai T; Makino T; Kagabu T
    Int J Fertil; 1969; 14(3):241-9. PubMed ID: 5812146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breastfeeding, amenorrhea and contraceptive practice among postpartum women in Zibo, China.
    Zhang LY; Liu YR; Shah IH; Tian KW; Zhang LH
    Eur J Contracept Reprod Health Care; 2002 Sep; 7(3):121-6. PubMed ID: 12428929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four years' experience with the TCu 220C, a long-acting multisleeved copper intrauterine device.
    Thiery M; Van Der Pas H; Van Kets H; Boogers W; Haspels A; Amy J-j
    Adv Plan Parent; 1979; 14(1):21-6. PubMed ID: 12335870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
    Jensen HH; Blaabjerg J; Lyndrup J
    Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating the Lactational Amenorrhea Method into a family planning program in Ecuador.
    Wade KB; Sevilla F; Labbok MH
    Stud Fam Plann; 1994; 25(3):162-75. PubMed ID: 7940621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on a new intrauterine contraceptive device the Beospir in a rural community.
    El-salam AF; Makhlouf AM
    Ain Shams Med J; 1977; 28(1-2):95-7. PubMed ID: 12309671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of breastfeeding on IUD performance.
    Cole LP; McCann MF; Higgins JE; Waszak CS
    Am J Public Health; 1983 Apr; 73(4):384-8. PubMed ID: 6829821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The "M"-IUD: a five year follow-up study in Ljubljana.
    Andolsek L; Bernard RP; Kozuh-Novak M; Thomas M
    Adv Plan Parent; 1975; 10(1):8-15. PubMed ID: 1164991
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of haemorrhage during insertion of IUD].
    Nesit V; Valenta M
    Cesk Gynekol; 1975 Mar; 40(2):137-9. PubMed ID: 1131935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.